35th World Summit on COVID-19 (Part VI)
  • Follow

Accepted Abstracts

COVID-19 and Aortic Thrombosis: A Case Report

Mamtha Balla*
University of Toledo, USA.

Citation: Balla M (2022) COVID-19 and Aortic Thrombosis: A Case Report. SciTech Central COVID-19.

Received: November 14, 2022         Accepted: November 16, 2022         Published: November 16, 2022


Coronavirus disease 2019 (COVID-19) is an infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It is known to cause a myriad of symptoms ranging from mild respiratory illness to severe pneumonia and acute respiratory distress. Since its discovery in late 2019 in Wuhan, China, the virus has caused a devastating worldwide pandemic. Although COVID-19 most commonly causes respiratory symptoms, complications such as hypercoagulability are now known to occur in some patients. In this case report, we present a COVID-19 patient that suffered a stroke and was found to have an aortic thrombus. This case report discussed hypercoagulability and venous and arterial thrombosis in COVID-19 patients. We hope to highlight the importance of monitoring laboratory markers of hypercoagulability and thromboembolism symptoms in COVID-19 patients and encourage appropriate prophylaxis and treatment with anticoagulants when necessary. Given the nature of the syndrome, it is unclear whether or not a causal relationship exists However, given the growing number of reported cases, physicians should maintain awareness of this possible complication when evaluating COVID-19 patients.
Keywords: Covid- 19, Complications of COVID-19, Aortic thrombus